Form 4: Amgen SVP Derek Miller Reports Acquisition of 1,311 Shares of Common Stock

Amgen's SVP of Human Resources, Derek Miller, reports acquiring 1,311 shares of common stock on March 6, 2024, bringing his total holdings to 8,863 shares.

Summary

• On March 6, 2024, Derek Miller, SVP of Human Resources at Amgen, acquired 1,311 shares of Amgen common stock.
• The acquisition was made directly.
• Following the transaction, Miller's total beneficial ownership of Amgen common stock is 8,863 shares.
• These shares include restricted stock units (RSUs) that will vest at various dates in the future.
• The RSUs are part of the Amgen Inc. 2009 Equity Incentive Plan.
• The shares also include dividend equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction. Executive acquiring shares is generally a positive sign, but not significantly impactful.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Executive stock ownership is a common practice in publicly traded companies like Amgen. It aligns the executive's interests with those of the shareholders.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to incentivize performance and long-term value creation.
• The vesting schedules for RSUs are typical, designed to retain executives and reward continued service.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates